{"pageContent": "Background: Androgen-deprivation therapy (ADT) causes bone loss and fractures. Guidelines recommend bone density testing before and during ADT to characterize fracture risk. The authors of the current report assessed bone density testing among men who received ADT for \u2265 1 year.", "metaData": {"source": "Ca2+ clearance mechanisms in cancer cell lines and stromal cells of the prostate\nhttps://pubmed.ncbi.nlm.nih.gov/24037789/"}}